Skip to main content

Table 1 MCDPT and MVD expression, STLBS and STLAS levels as a function of clinicopathological characteristics in a series of 105 breast cancer patients

From: Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance

Variable No. of patients No. of tumours with high MCDPT * (%) No. of tumours with high MVD ** (%) No. of tumours with high STLBS *** (%) No. of tumours with high STLAS **** (%)
Age, years      
Range 26-86 105     
Median 58 105     
< 58 years 48 25 (53) 29 (58) 26 (55) 27 (56)
≥ 58 years 57 33 (58) 29 (51) 31 (54) 27 (48)
Menopausal status      
Premenopausal 43 24 (55) 21 (49) 23 (53) 25 (59)
Postmenopausal 62 36 (58) 31 (50) 32 (52) 34 (55)
Hystological type      
Ductal 78 41 (52) 37 (47) 38 (49) 40 (51)
Lobular 27 14 (51) 16 (58) 13 (48) 15 (55)
Tumour size      
pT1 49 26 (54) 25 (55) 27 (55) 24 (49)
pT2 36 16 (44) 19 (52) 18 (51) 17 (47)
pT3 20 12 (59) 11 (54) 10 (50) 9 (47)
Nodal status      
pN0 44 19 (43) 21 (48) 20 (46) 23 (52)
pN1–2 61 29 (48) 32 (53) 33 (54) 35 (58)
Cytohistological grade      
G1 37 19 (52) 22 (60) 21 (58) 18 (48)
G2 45 20 (44) 23 (51) 21 (47) 22 (49)
G3 23 12 (54) 10 (45) 11 (50) 13 (56)
Estrogen receptor status      
Negative 29 16 (55) 17 (58) 13 (46) 14 (55)
Positive 76 37 (49) 42 (55) 36 (48) 41 (54)
Progesteron receptor status      
Negative 34 19 (55) 16 (47) 18 (53) 17 (50)
Positive 71 36 (51) 35 (49) 39 (55) 37 (52)
c-erbB-2 status      
Negative 69 37 (54) 33 (48) 35 (51) 37 (53)
Positive 36 22 (61) 20 (55) 19 (52) 17 (48)
  1. *Median cut-off value: 8 cells per 400 field.
  2. **Median cut-off value: 23 microvessels per 400 field.
  3. ***Median cut-off value: 6.4.
  4. ****Median cut-off value: 4.8.
\